Earnings
PRTK
8.02
+3.48%
0.27
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
105.16M
20.00M
--
15.73M
--
--
0.00
--
14.55M
--
7.78M
891.00K
164.12M
2.97M
--
--
--
829.00K
--
--
8.93M
12.74M
176.85M
--
1.81M
0.00
--
--
--
--
--
20.83M
--
--
--
1.31M
23.95M
250.47M
--
--
--
4.69M
255.16M
279.11M
46.00K
705.49M
-807.80M
--
--
--
-102.26M
-102.26M
176.85M
FY 2019-12-31
102.30M
113.08M
--
9.58M
--
--
0.00
--
11.58M
--
6.49M
324.00K
243.35M
3.74M
--
0.00
--
829.00K
--
--
3.15M
7.72M
251.08M
--
4.12M
0.00
--
--
--
--
--
17.70M
--
--
--
2.39M
24.20M
260.73M
--
--
--
5.80M
266.53M
290.73M
40.00K
671.50M
-711.26M
--
--
--
-39.65M
-39.65M
251.08M
FY 2018-12-31
46.99M
203.36M
--
249.00K
--
--
0.00
--
--
--
4.38M
266.00K
255.24M
1.17M
--
42.49M
--
829.00K
0.00
--
460.00K
44.95M
300.19M
--
2.09M
0.00
--
--
--
--
--
15.62M
--
--
--
--
17.71M
228.96M
--
--
--
5.95M
234.91M
252.61M
32.00K
630.14M
-582.47M
--
--
--
47.58M
47.58M
300.19M
FY 2017-12-31
35.42M
116.31M
--
5.89M
--
--
0.00
--
--
--
2.71M
162.00K
160.49M
1.71M
--
--
--
829.00K
142.00K
--
530.00K
3.21M
163.70M
--
3.68M
0.00
--
--
--
--
--
13.11M
--
--
--
--
16.79M
59.26M
--
--
--
5.17M
64.43M
81.22M
28.00K
552.72M
-470.11M
--
--
--
82.48M
82.48M
163.70M
FY 2016-12-31
52.96M
75.08M
--
323.00K
--
--
0.00
--
--
--
2.92M
817.00K
132.10M
1.19M
--
--
--
829.00K
1.01M
--
600.00K
3.63M
135.73M
--
4.47M
0.00
--
--
--
--
--
15.89M
--
--
--
56.00K
20.41M
39.63M
--
--
--
4.10M
43.73M
64.14M
23.00K
451.95M
-380.36M
--
--
--
71.59M
71.59M
135.73M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out PRTK latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Paratek Pharms recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.